Edap TMS SA (EDAP)
2.55
+0.06
(+2.41%)
USD |
NASDAQ |
Nov 22, 11:55
Edap TMS Total Assets (Quarterly): 88.28M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 88.28M |
| June 30, 2024 | 88.07M |
| March 31, 2024 | 96.20M |
| December 31, 2023 | 101.20M |
| September 30, 2023 | 98.72M |
| June 30, 2023 | 103.60M |
| March 31, 2023 | 109.88M |
| December 31, 2022 | 108.44M |
| September 30, 2022 | 103.01M |
| June 30, 2022 | 84.92M |
| March 31, 2022 | 85.33M |
| December 31, 2021 | 87.44M |
| September 30, 2021 | 85.47M |
| June 30, 2021 | 88.80M |
| March 31, 2021 | 62.48M |
| December 31, 2020 | 67.89M |
| September 30, 2020 | 60.63M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 59.45M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 55.75M |
| September 30, 2018 |
| Date | Value |
|---|---|
| June 30, 2018 | 53.97M |
| March 31, 2018 | |
| December 31, 2017 | 56.26M |
| September 30, 2017 | |
| June 30, 2017 | 52.26M |
| March 31, 2017 | |
| December 31, 2016 | 49.25M |
| September 30, 2016 | |
| June 30, 2016 | 51.94M |
| March 31, 2016 | |
| December 31, 2015 | 42.18M |
| September 30, 2015 | |
| June 30, 2015 | 38.02M |
| March 31, 2015 | |
| December 31, 2014 | 39.10M |
| September 30, 2014 | |
| June 30, 2014 | 44.45M |
| March 31, 2014 | |
| December 31, 2013 | 37.11M |
| September 30, 2013 | |
| June 30, 2013 | 35.11M |
| March 31, 2013 | |
| December 31, 2012 | 40.26M |
| September 30, 2012 | 32.06M |
| June 30, 2012 | 38.41M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
59.45M
Minimum
Dec 2019
109.88M
Maximum
Mar 2023
87.77M
Average
88.18M
Median
Total Assets (Quarterly) Benchmarks
| DBV Technologies SA | 93.06M |
| Cellectis SA | 395.88M |
| Genfit SA | 192.20M |
| Adaptimmune Therapeutics PLC | 317.44M |
| Akari Therapeutics PLC | 2.734M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 40.66M |
| Shareholders Equity (Quarterly) | 47.63M |
| Debt to Equity Ratio | 0.089 |
| Current Ratio | 2.176 |
| Net Debt Paydown Yield | 0.11% |